The skillful help of Mrs. M. C. de Boer-Bisschops, Mrs. C. Kosterman-Claassen, Mr. R. Lodewijks, and Mrs. U. M. R. Vrij in performing the CEA assay, and of Mrs. A. Graafmans and Mrs. A. J. M. Pieterson-Scholts in collecting and handling the bloodsamples, is gratefully acknowledged.
Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix
β Scribed by Kenter, G; Bonfrer, JMG; Heintz, APM
- Book ID
- 109835843
- Publisher
- Nature Publishing Group
- Year
- 1987
- Tongue
- English
- Weight
- 370 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Optimal timing of the measurement of serum squamous cell carcinoma (SCC) antigen during radiation therapy (RT) and its significance for predicting the response of cervical carcinoma patients as early as possible remain unknown. ## METHODS Sixtyβthree patients with SCC o
Correlations between age and several prognostic factors, such as histologic cell type, depth of invasion, intravascular invasion, and lymph node metastases (LNM), were analyzed in squamous cell carcinoma of the cervix (SCC). A total of 380 patients with Stage IB or more advanced SCC underwent radica
An indirect immunofluorescence assay is described which specifically detects antibodies against cervical carcinoma-associated membrane antigens. Cells from the ME-180 cervical carcinoma cell line were used as target cells. Sera had to be absorbed with pooled tonsillar lymphocytes prior to use, to re